1 day+16.40%
1 week+39.16%
Current month+21.88%
1 month+17.29%
1 week 14,260
Extreme 14260
21,950
1 month 14,200
Extreme 14200
21,950
Current year 9,900
Extreme 9900
21,950
1 year 9,900
Extreme 9900
21,950
3 years 9,900
Extreme 9900
21,950
5 years 9,900
Extreme 9900
21,950
10 years 9,900
Extreme 9900
21,950
Manager TitleAgeSince
Chief Executive Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member 66 -
Change 5-day change 1-year change 3-year change Capi.($)
+16.40%+39.16% - - 657M
+0.59%+3.31%+1.03%+24.53% 46.28B
+1.30%+1.58%+44.15%+35.50% 43.85B
+0.95%-6.02%+342.72%+532.41% 40.93B
+4.23%+3.35%+9.35%+94.73% 39.89B
+1.11%+1.80%+11.52%+43.15% 29.5B
+1.94%+4.84%+25.19%+159.21% 17.09B
+0.37%-10.32% - - 15.55B
+2.12%+10.41%+24.78%+39.05% 15.22B
+0.24%+25.43%-11.57% - 14.05B
Average +2.91%+7.76%+55.90%+132.65% 26.3B
Weighted average by Cap. +1.55%+2.18%+70.37%+141.13%

Financials

2024 2025
Net sales 3.53B 2.57M 2.24M 2.11M 1.92M 3.6M 246M 3.61M 25.26M 9.73M 125M 9.65M 9.43M 404M -
Net income 21.46B 15.61M 13.61M 12.82M 11.67M 21.89M 1.5B 21.91M 154M 59.17M 762M 58.63M 57.33M 2.46B -26.45B -19.24M -16.77M -15.8M -14.39M -26.98M -1.84B -27.01M -189M -72.93M -939M -72.27M -70.67M -3.03B
Net Debt - -
Logo Ingenia Therapeutics Inc.
INGENIA Therapeutics Inc is a clinical-stage biotech company. The Company focused on the treatment of damaged capillary-associated indications with clinical needs. The Company is engaged in discovery and development of therapeutic antibody candidates for patient populations suffering from microvascular disorders and progressive chronic diseases. By modifying endothelial cell signaling, the Company provides vascular therapeutics.
Employees
-
Date Price Change Volume
21/09/26 ₩21,500.00 +16.40% 7,125,507
18/09/26 ₩18,470.00 +3.01% 4,855,181
17/09/26 ₩17,930.00 +14.28% 3,685,975
16/09/26 ₩15,690.00 +3.56% 446,537
15/09/26 ₩15,150.00 +6.32% 1,055,948
  1. Stock Market
  2. Stocks
  3. A950260 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!